Status:
UNKNOWN
Assessing Antibody Responsiveness to Hepatitis B Vaccine in Aged Lymphoma Patients Undergoing Treatment With Rituximab
Lead Sponsor:
Rambam Health Care Campus
Collaborating Sponsors:
Technion, Israel Institute of Technology
Conditions:
Lymphoma
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
Background: The ability of the immune system to function declines with aging. This is reflected by a marked decrease in the responsiveness to vaccinations and to infectious agents. Consequentially, t...
Eligibility Criteria
Inclusion
- 55 years and older
- lymphoma
- rituximab
Exclusion
- disease remission
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00863187
Start Date
February 1 2009
Last Update
March 17 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.